Literature DB >> 30949791

Program Development of Integrated Psychological Services for Hospitalized Patients with Intravenous Drug Use Histories.

Andrew D Gill1, Tara McCuin2, Marlene Maron2.   

Abstract

Amid rising trends in opioid use, hospitalizations for health conditions secondary to intravenous drug use are becoming more common. Such patients often require prolonged hospitalizations and frequently present with substance use histories, co-occurring mental health diagnoses, and unique behavioral health needs. These issues can adversely impact completion of medical treatment and place added burden on hospital staff. There is a growing need for medical institutions to develop policies and procedures which address the specific emotional, behavioral, and substance use needs of this patient population. Because guidelines for doing so are sparse in the literature, this study outlines the University of Vermont Medical Center's process of developing an in-hospital care agreement intended to (1) increase patient access to in-hospital need assessments, psychotherapy, and medication for opioid use disorders, (2) increase referrals for opioid use treatment beyond hospitalization, (3) standardize staff response to common challenging behaviors, and (4) provide staff with education and support for interacting with patients in effective ways. The multidisciplinary process of developing this care agreement, its specific details, lessons learned, and anticipated future directions are also discussed.

Entities:  

Keywords:  Hospital; Integrated; Policy; Program development; Substance use

Mesh:

Year:  2020        PMID: 30949791     DOI: 10.1007/s10880-019-09616-4

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  21 in total

1.  Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers.

Authors:  D D Chitwood; D C McBride; M T French; M Comerford
Journal:  Subst Use Misuse       Date:  1999 Mar-Apr       Impact factor: 2.164

2.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

3.  Integrating primary medical care with addiction treatment: a randomized controlled trial.

Authors:  C Weisner; J Mertens; S Parthasarathy; C Moore; Y Lu
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

4.  Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Authors:  Kathleen M Carroll; Samuel A Ball; Charla Nich; Steve Martino; Tami L Frankforter; Christiane Farentinos; Lynn E Kunkel; Susan K Mikulich-Gilbertson; Jon Morgenstern; Jeanne L Obert; Doug Polcin; Ned Snead; George E Woody
Journal:  Drug Alcohol Depend       Date:  2005-09-28       Impact factor: 4.492

5.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

6.  Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors:  R Matthew Gladden; Pedro Martinez; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

Review 7.  The influence of substance use on adolescent brain development.

Authors:  L M Squeglia; J Jacobus; S F Tapert
Journal:  Clin EEG Neurosci       Date:  2009-01       Impact factor: 1.843

8.  Patient perspectives of an integrated program of medical care and substance use treatment.

Authors:  Mari-Lynn Drainoni; Caitlin Farrell; Amy Sorensen-Alawad; Joseph N Palmisano; Christine Chaisson; Alexander Y Walley
Journal:  AIDS Patient Care STDS       Date:  2014-01-15       Impact factor: 5.078

9.  Aggression, impulsivity, personality traits, and childhood trauma of prisoners with substance abuse and addiction.

Authors:  Chiara Cuomo; Marco Sarchiapone; Massimo Di Giannantonio; Michele Mancini; Alec Roy
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

10.  The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization.

Authors:  Thomas P O'Toole; Robin A Pollini; Daniel E Ford; George Bigelow
Journal:  Med Care       Date:  2007-11       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.